Weston Nichols

Director/Board Member at CRINETICS PHARMACEUTICALS, INC.

Net worth: 831 660 $ as of 30/06/2026

41 year

89 connections

Finance

Consumer Services

Health Technology

Profile

Weston Agnew Nichols is currently an Independent Director at Crinetics Pharmaceuticals, Inc. since 2018 and serves as CIO, Limited Partner, and Chief Compliance Officer at Lynx1.
Capital Management LP since 2020.
Former roles include Director at Perceptive Advisors (Private Equity) from 2016 to 2020, Analyst at Perceptive Advisors LLC from 2016 to 2020, Analyst at Balyasny Asset Management LP in 2015, and Biotechnology Equity Research Associate at Truist Securities, Inc. Education includes an undergraduate degree from Cornell University conferred in 2008 and a doctorate from the California Institute of Technology.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
CRINETICS PHARMACEUTICALS INC 0.02%	18/06/2026	22,225 ( 0.02% )	831 660 $	30/06/2026

Weston Nichols active positions

Companies	Position	Start
CRINETICS PHARMACEUTICALS, INC.	Director/Board Member	01/02/2018
Lynx1 Capital Management LP Lynx1 Capital Management LP Investment ManagersFinance Provides investment advice	Chief Executive Officer	01/05/2020

All active positions of Weston Nichols

Former positions of Weston Nichols

Companies	Position	End
Perceptive Advisors (Private Equity) Perceptive Advisors (Private Equity) Investment ManagersFinance Perceptive Advisors invests in both public and private middle market companies located across the globe. The firm focuses across a broad range of sectors and industries. It participates in seed, early, later stage and growth transactions in the form of equity and debt with an investment size of USD 10 – 300 million. The firm acts as lead investor and takes a seat on a board of directors.	Private Equity Analyst	31/03/2020
Perceptive Advisors LLC Perceptive Advisors LLC Investment ManagersFinance Perceptive Advisors focuses on investment opportunities in healthcare, with an emphasis on biotechnology. The firm believes that significant opportunities exist in biotechnology due to pervasive underlying market inefficiencies and volatility.	Director/Board Member	01/03/2020
Balyasny Asset Management LP Balyasny Asset Management LP Investment ManagersFinance BAM aims to deliver consistent, uncorrelated absolute returns in all market environments. The firm manages multi-strategy investment funds which maintain a concentrated private equity portfolio. Their investment advisory services reflect a blend of strategies including fundamental long/short equity, macro & rates, systematic trading and event & credit investing. BAM’s long/short equity and equity trading strategies include (but are not limited to) investments and trading in the following market sectors: Energy, Health Care, Financials, Industrials, Information Technology, Consumer Staples and Consumer Discretionary.	Analyst-Equity	31/12/2015
Truist Securities, Inc. Truist Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services	Analyst-Equity	-

See the detail of Weston Nichols's experience

Training of Weston Nichols

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Weston Nichols's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	8
Truist Securities, Inc. Truist Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services	Finance
Balyasny Asset Management LP Balyasny Asset Management LP Investment ManagersFinance BAM aims to deliver consistent, uncorrelated absolute returns in all market environments. The firm manages multi-strategy investment funds which maintain a concentrated private equity portfolio. Their investment advisory services reflect a blend of strategies including fundamental long/short equity, macro & rates, systematic trading and event & credit investing. BAM’s long/short equity and equity trading strategies include (but are not limited to) investments and trading in the following market sectors: Energy, Health Care, Financials, Industrials, Information Technology, Consumer Staples and Consumer Discretionary.	Finance
Perceptive Advisors LLC Perceptive Advisors LLC Investment ManagersFinance Perceptive Advisors focuses on investment opportunities in healthcare, with an emphasis on biotechnology. The firm believes that significant opportunities exist in biotechnology due to pervasive underlying market inefficiencies and volatility.	Finance
Cornell University Cornell University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
California Institute of Technology California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Crinetics Pharmaceuticals, Inc. Crinetics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets therapeutics for endocrine-related diseases	Health Technology
Perceptive Advisors (Private Equity) Perceptive Advisors (Private Equity) Investment ManagersFinance Perceptive Advisors invests in both public and private middle market companies located across the globe. The firm focuses across a broad range of sectors and industries. It participates in seed, early, later stage and growth transactions in the form of equity and debt with an investment size of USD 10 – 300 million. The firm acts as lead investor and takes a seat on a board of directors.	Finance
Lynx1 Capital Management LP Lynx1 Capital Management LP Investment ManagersFinance Provides investment advice	Finance